Dothan AL 克罗恩病临床试验
5项针对 克罗恩病的研究正在 Dothan及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
招募中2 期
- Digestive Health Specialists /ID# 280827, Dothan
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
招募中2 期
- Digestive Health Specialists /ID# 266216, Dothan
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
招募中3 期
- Digestive Health Specialists of the Southeast, Dothan
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
招募中3 期
- Digestive Health Specialists, Dothan
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
招募中4 期
- Digestive Health Specialsits, Dothan
其他城市的 克罗恩病试验
- New York City, NY35 项研究
- Cleveland, OH19 项研究
- St. Louis, MO19 项研究
- Boston, MA19 项研究
- Miami, FL19 项研究
- Orlando, FL17 项研究
- Houston, TX17 项研究
- Atlanta, GA17 项研究
- Tyler, TX16 项研究
- San Diego, CA15 项研究
- San Antonio, TX15 项研究
- Los Angeles, CA15 项研究
Dothan的其他研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月5日。每项研究自行设定入选标准，由研究团队决定谁能参与。